These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19908312)

  • 1. Cognitive impulsivity in Parkinson's disease patients: assessment and pathophysiology.
    Robert G; Drapier D; Verin M; Millet B; Azulay JP; Blin O
    Mov Disord; 2009 Dec; 24(16):2316-27. PubMed ID: 19908312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic deep brain stimulation and impulse control in Parkinson's disease.
    Hälbig TD; Tse W; Frisina PG; Baker BR; Hollander E; Shapiro H; Tagliati M; Koller WC; Olanow CW
    Eur J Neurol; 2009 Apr; 16(4):493-7. PubMed ID: 19236471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism.
    Frank MJ; Samanta J; Moustafa AA; Sherman SJ
    Science; 2007 Nov; 318(5854):1309-12. PubMed ID: 17962524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep brain stimulation of the subthalamic nucleus modulates sensitivity to decision outcome value in Parkinson's disease.
    Seymour B; Barbe M; Dayan P; Shiner T; Dolan R; Fink GR
    Sci Rep; 2016 Sep; 6():32509. PubMed ID: 27624437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
    Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G
    Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the effects of disease and treatment on impulsivity in Parkinson's disease.
    Simioni AC; Dagher A; Fellows LK
    J Int Neuropsychol Soc; 2012 Nov; 18(6):942-51. PubMed ID: 23079116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep brain stimulation and behavioural changes: is comedication the most important factor?
    Lulé D; Heimrath J; Pinkhardt EH; Ludolph AC; Uttner I; Kassubek J
    Neurodegener Dis; 2012; 9(1):18-24. PubMed ID: 21778695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulsivity and Parkinson's disease: more than just disinhibition.
    Antonelli F; Ray N; Strafella AP
    J Neurol Sci; 2011 Nov; 310(1-2):202-7. PubMed ID: 21683964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical power of studies examining the cognitive effects of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Woods SP; Rippeth JD; Conover E; Carey CL; Parsons TD; Tröster AI
    Clin Neuropsychol; 2006 Feb; 20(1):27-38. PubMed ID: 16393919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease.
    Djamshidian A; O'Sullivan SS; Foltynie T; Aviles-Olmos I; Limousin P; Noyce A; Zrinzo L; Lees AJ; Averbeck BB
    J Parkinsons Dis; 2013; 3(2):139-44. PubMed ID: 23938343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism(s) of deep brain stimulation and insights into cognitive outcomes in Parkinson's disease.
    Naskar S; Sood SK; Goyal V; Dhara M
    Brain Res Rev; 2010 Oct; 65(1):1-13. PubMed ID: 20457181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study.
    Zangaglia R; Pacchetti C; Pasotti C; Mancini F; Servello D; Sinforiani E; Cristina S; Sassi M; Nappi G
    Mov Disord; 2009 Aug; 24(11):1621-8. PubMed ID: 19514093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporary deterioration of executive function after subthalamic deep brain stimulation in Parkinson's disease.
    Yamanaka T; Ishii F; Umemura A; Miyata M; Horiba M; Oka Y; Yamada K; Okita K; Matsukawa N; Ojika K
    Clin Neurol Neurosurg; 2012 May; 114(4):347-51. PubMed ID: 22176916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss.
    Aarts E; Helmich RC; Janssen MJ; Oyen WJ; Bloem BR; Cools R
    Neuroimage; 2012 Feb; 59(4):3339-46. PubMed ID: 22166793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological gambling in Parkinson's disease: what are the risk factors and what is the role of impulsivity?
    Heiden P; Heinz A; Romanczuk-Seiferth N
    Eur J Neurosci; 2017 Jan; 45(1):67-72. PubMed ID: 27623191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroscience. Two therapies release different brakes on impulsive behavior.
    Miller G
    Science; 2007 Oct; 318(5850):553. PubMed ID: 17962532
    [No Abstract]   [Full Text] [Related]  

  • 17. [Placebo effect in Parkinson's disease].
    Miwa H
    No To Shinkei; 2007 Feb; 59(2):139-46. PubMed ID: 17315755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine dysregulation syndrome after deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    De la Casa-Fages B; Grandas F
    J Neurol Sci; 2012 Jan; 312(1-2):191-3. PubMed ID: 21872889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.